论文部分内容阅读
帕拉米韦水合物是美国BioCryst公司开发的以流感病毒表面糖蛋白神经氨酸酶为作用靶点的新型环戊烷类抗流感病毒制剂,是世界首个静脉给药制
Peramivir hydrate is a new type of cyclopentane anti-influenza virus preparation developed by BioCryst Company that targets the surface glycoprotein neuraminidase of influenza virus. It is the first intravenous drug delivery system in the world